AInvest★★★★★3-DAY FREE
Catch pre-market movers with AI signals.
Claim Trial
IMCR
Immunocore·NASDAQ
--
--(--)
--
--(--)
Immunocore (IMCR) Revenue Breakdown
Immunocore (IMCR) Revenue Breakdown: Q2 2026 Business & Regional Performance
Immunocore (IMCR) reported total revenue of 115.93M USD in Q2 2026, with its core business segment Revenue From Sale of Therapies, Net contributing 100.00%. Regionally, United States remained the largest market, accounting for 64.64% of total revenue. Explore Immunocore's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Immunocore (IMCR) reported total revenue of 115.93M USD in Q2 2026, with its core business segment Revenue From Sale of Therapies, Net contributing 100.00%. Regionally, United States remained the largest market, accounting for 64.64% of total revenue. Explore Immunocore's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is the market's earnings forecast for Immunocore next quarter?What factors drove the changes in Immunocore's revenue and profit?What does Immunocore do and what are its main business segments?What were the key takeaways from Immunocore’s earnings call?What is Immunocore's gross profit margin?What guidance did Immunocore's management provide for the next earnings period?What is the revenue and EPS growth rate for Immunocore year over year?What were the key takeaways from Immunocore's earnings call?
